101 related articles for article (PubMed ID: 32143670)
1. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
Li M; Pan M; You C; Zhao F; Wu D; Guo M; Xu H; Shi F; Zheng D; Dou J
Breast Cancer Res; 2020 Mar; 22(1):26. PubMed ID: 32143670
[TBL] [Abstract][Full Text] [Related]
2. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
3. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
[TBL] [Abstract][Full Text] [Related]
4. LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells.
Xu R; Zhu X; Chen F; Huang C; Ai K; Wu H; Zhang L; Zhao X
Cancer Cell Int; 2018; 18():41. PubMed ID: 29559853
[TBL] [Abstract][Full Text] [Related]
5. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling.
Luo F; Zhang M; Sun B; Xu C; Yang Y; Zhang Y; Li S; Chen G; Chen C; Li Y; Feng H
Mol Cancer; 2024 Mar; 23(1):60. PubMed ID: 38520019
[TBL] [Abstract][Full Text] [Related]
6. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells.
Cui B; Luo Y; Tian P; Peng F; Lu J; Yang Y; Su Q; Liu B; Yu J; Luo X; Yin L; Cheng W; An F; He B; Liang D; Wu S; Chu P; Song L; Liu X; Luo H; Xu J; Pan Y; Wang Y; Li D; Huang P; Yang Q; Zhang L; Zhou BP; Liu S; Xu G; Lam EW; Kelley KW; Liu Q
J Clin Invest; 2019 Mar; 129(3):1030-1046. PubMed ID: 30688660
[TBL] [Abstract][Full Text] [Related]
7. miR-203 drives breast cancer cell differentiation.
Martínez-Illescas NG; Leal S; González P; Graña-Castro O; Muñoz-Oliveira JJ; Cortés-Peña A; Gómez-Gil M; Vega Z; Neva V; Romero A; Quintela-Fandino M; Ciruelos E; Sanz C; Aragón S; Sotolongo L; Jiménez S; Caleiras E; Mulero F; Sánchez C; Malumbres M; Salazar-Roa M
Breast Cancer Res; 2023 Aug; 25(1):91. PubMed ID: 37542268
[TBL] [Abstract][Full Text] [Related]
8. A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer
Bolli E; O'Rourke JP; Conti L; Lanzardo S; Rolih V; Christen JM; Barutello G; Forni M; Pericle F; Cavallo F
Oncoimmunology; 2018; 7(3):e1408746. PubMed ID: 29399412
[TBL] [Abstract][Full Text] [Related]
9. A protein assembly mediates Xist localization and gene silencing.
Pandya-Jones A; Markaki Y; Serizay J; Chitiashvili T; Mancia Leon WR; Damianov A; Chronis C; Papp B; Chen CK; McKee R; Wang XJ; Chau A; Sabri S; Leonhardt H; Zheng S; Guttman M; Black DL; Plath K
Nature; 2020 Nov; 587(7832):145-151. PubMed ID: 32908311
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA XIST promotes the progression of breast cancer by sponging miR-125b-5p to modulate NLRC5.
Zong Y; Zhang Y; Hou D; Xu J; Cui F; Qin Y; Sun X
Am J Transl Res; 2020; 12(7):3501-3511. PubMed ID: 32774715
[TBL] [Abstract][Full Text] [Related]
11. miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression.
Li M; Pan M; Wang J; You C; Zhao F; Zheng D; Guo M; Xu H; Wu D; Wang L; Dou J
Mol Ther Oncolytics; 2020 Sep; 18():70-82. PubMed ID: 32637582
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DHRS4-AS1 Inhibits the Stemness of NSCLC Cells by Sponging miR-224-3p and Upregulating TP53 and TET1.
Yan F; Zhao W; Xu X; Li C; Li X; Liu S; Shi L; Wu Y
Front Cell Dev Biol; 2020; 8():585251. PubMed ID: 33425890
[TBL] [Abstract][Full Text] [Related]
13. SOX2 Regulates lncRNA CCAT1/MicroRNA-185-3p/FOXP3 Axis to Affect the Proliferation and Self-Renewal of Cervical Cancer Stem Cells.
Zhang L; Guo C; Ji T; Chen X
Nanoscale Res Lett; 2021 Jan; 16(1):2. PubMed ID: 33394184
[TBL] [Abstract][Full Text] [Related]
14. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.
Zhou T; Wu L; Ma N; Tang F; Yu Z; Jiang Z; Li Y; Zong Z; Hu K
Cell Death Dis; 2020 Dec; 11(12):1071. PubMed ID: 33318478
[TBL] [Abstract][Full Text] [Related]
15. SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells.
Zagorac S; de Giorgio A; Dabrowska A; Kalisz M; Casas-Vila N; Cathcart P; Yiu A; Ottaviani S; Degani N; Lombardo Y; Tweedie A; Nissan T; Vance KW; Ulitsky I; Stebbing J; Castellano L
Cancer Res; 2021 Feb; 81(3):580-593. PubMed ID: 33172932
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SOX21-AS1 enhances the stemness of breast cancer cells via the Hippo pathway.
Li L; Meng D; Wang R
FEBS Open Bio; 2021 Jan; 11(1):251-264. PubMed ID: 33103351
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor coactivator-1 enhances the stemness of glioblastoma by activating long noncoding RNA XIST/miR-152/KLF4 pathway.
Gong M; Wang X; Mu L; Wang Y; Pan J; Yuan X; Zhou H; Xing J; Wang R; Sun J; Liu Q; Zhang X; Wang L; Chen Y; Pei Y; Li S; Liu L; Zhao Y; Yuan Y
Cancer Sci; 2021 Feb; 112(2):604-618. PubMed ID: 33090636
[TBL] [Abstract][Full Text] [Related]
18. Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt/β-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma.
Dai W; Jin X; Han L; Huang H; Ji Z; Xu X; Tang M; Jiang B; Chen W
Cell Death Dis; 2020 Sep; 11(9):743. PubMed ID: 32917852
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA GAS5 is critical for maintaining stemness and induces chemoresistance in cancer stem-like cells derived from HCT116.
Zhou X; Xiao D
Oncol Lett; 2020 May; 19(5):3431-3438. PubMed ID: 32269616
[TBL] [Abstract][Full Text] [Related]
20. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells.
You CZ; Xu H; Zhao FS; Dou J
Bull Exp Biol Med; 2024 Jan; 176(3):369-375. PubMed ID: 38340198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
